BD Veritor™ Plus Analyser

  • $749.99
    Unit price per 
Shipping calculated at checkout.


*Must be paired with BD Veritor System for Rapid Detection of SARS-CoV-2

The BD Veritor Plus system provides objective, lab-quality immunoassay test results for healthcare providers and laboratorians in physician offices, clinics, and hospitals—within minutes. The system streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. It can also help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV) and group A strep while the patient is still on site, which may facilitate decision making for earlier intervention.

The BD Veritor™ Plus System offers convenient point-of-care testing for SARS-CoV-2*, Influenza A+B, Group A Streptococcus, and respiratory syncytial virus and combines rapid, reliable results with ease of implementation and simple workflow options.

Confidence in your test results starts with a clear display screen

The BD Veritor™ Plus System displays clear results on a large, easy to read screen. A ‘+’ sign indicates the presence of respiratory pathogen, a ‘-‘ sign indicates absence. 

The BD Veritor™ Plus System can be optimized to meet your reporting needs. When deciding on the right option for your facility, it is important to consider testing volumes, site workflow plans, standardized reporting and staffing needs. 

The COVID Rapid testing system by BD via nasal swab is approved by Health Canada and the test result accuracy is 98%. The test is a bilateral nasal swab that gets dipped into our pre-filled reagent tube. Then three drops of the reagent are put on to the test cartridge to incubated for 15 minutes, once the 15 minutes is up then you can but the cartridge into the reader and it will tell you the result within 3 seconds.

 “Under the recent exemption for point of care testing from the LSCCLA, any health professional or trained individual can perform a point of care test that has been approved by Health Canada. The test must still be authorized by Health Canada.”  the letter from the Ministry of Health-the exemption memo is attached.